HutchMed Initiates Rolling NDA Submission for Elunate to US FDA
Hutchison China Meditech (HutchMed; HKG: 0013, NASDAQ: HCM) has announced the initiation of a rolling...
PCAOB Report Signals Relief for US-Listed Chinese Biotechs
A report issued last week by the US Public Company Accounting Oversight Board (PCAOB) indicated...
Luye Pharma’s Shandong Boan Biotechnology IPOs on Hong Kong Stock Exchange
China-based Luye Pharma Group’s (HKG: 2186) controlling subsidiary Shandong Boan Biotechnology Co., Ltd has officially...
Simcere Pharmaceutical Completes Enrollment for SIM0417 COVID-19 Drug Trial
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced the completion of enrollment of 1,208 patients...
Neurophth’s NFS-02 Gene Therapy Gets FDA IND Approval for LHON Treatment
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced obtaining Investigational New Drug (IND) approval...
TG ImmunoPharma Gains FDA Approval for Phase I Study of Anti-PVRIG Antibody
China-based TG ImmunoPharma Co., Ltd has announced receiving the go-ahead from the US FDA to...
Adagene Initiates International Study for ADG126 in Hepatocellular Carcinoma
China-based biotech Adagene Inc. (NASDAQ: ADAG), which also operates out of San Diego, California, has...
Jiangsu Recbio’s Herpes Zoster Vaccine REC610 Gets Clinical Trial Approval in Philippines
China-based vaccine maker Jiangsu Recbio Technology Co., Ltd (HKG: 2179) has announced receiving clinical trial...
Endo International Licenses TLC’s Phase III Nanomedicine for OA Knee Pain
Ireland-based Endo International plc (NASDAQ: ENDP) has announced a licensing deal between its subsidiary Endo...
GenFleet and Merck KGaA Partner on European Clinical Study for KRAS G12C Inhibitor
China-based GenFleet Therapeutics Inc. has announced a European multi-center clinical study and drug supply agreement...
Blue Sail Medical’s Microcatheter Receives NMPA Marketing Approval
China’s Blue Sail Medical Co., Ltd (SHE: 002382) has announced obtaining marketing approval from the...
Meihua Medtech Secures Over RMB 100M in Series B Financing Led by Eight Roads and Sunland
China’s Zhuhai Meihua Medical Technology Co., Ltd, a leading clinical microbiology laboratory overall solutions provider,...
InnerMedical Secures RMB 300M in Series D Funding Led by Green Pine and Simiao
InnerMedical Co., Ltd, a leading chronic disease diagnosis and treatment solutions provider based in Shenzhen,...
Novartis China Establishes Health Development Fund in Boao Lecheng
Novartis (NYSE: NVS) China has announced the establishment of a health development fund, a significant...
Henlius’ Serplulimab Receives Orphan Drug Designation in Europe for SCLC
Shanghai Henlius Biotech (HKG: 2696) has announced receiving orphan drug designation (ODD) status from the...
XingImaging and Mitro Biotech Partner for Contract Research Services in China
US-based XingImaging LLC and China-based Mitro Biotech Co., Ltd have announced a partnership to provide...
Doer Bio and MSD Collaborate on Clinical Trial for Anti-Claudin18.2 Antibody DR30303
China-based Zhejiang Doer Biologics Co., Ltd has announced a clinical trial collaboration agreement with US...
WuXi Biologics’ Shanghai Subsidiary Removed from US UVL
China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) announced that its...
Liaoning Publishes Fourth Round of Volume-Based Procurement Winning Bids
The Liaoning drug and medical consumables centralized procurement website has published the fourth round of...
Cryofocus Medtech Set for IPO on Hong Kong Stock Exchange
China-based Cryofocus Medtech (Shanghai) Co., Ltd, a minimally invasive interventional cryotherapy device maker, is set...